Trade MAZE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Maze Therapeutics, Inc. (MAZE) is trading at US$22.52, down 3.92% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.63B. Over the past 52 weeks, MAZE has traded between US$22.01 and US$53.65. On Syfe you can trade MAZE with $0 commission and add it to your watchlist.
| Previous close | US$23.44 |
|---|---|
| Market cap | US$1.63B |
| 52-week range | US$22.01 – US$53.65 |
| Volume | 1.49M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 29, 2017 and is headquartered in San Francisco, CA.
Year: 2025
-- Earnings Flash (MAZE) Maze Therapeutics Posts Q2 Loss $0.76 per Share, vs. FactSet Est of $0.72 Loss
Aug 11, 8:33 PM · MT Newswires
Maze Therapeutics Insider Sold Shares Worth $393,354, According to a Recent SEC Filing
May 18, 9:10 PM · MT Newswires
-- Earnings Flash (MAZE) Maze Therapeutics, Inc. Reports Q1 Revenue $20.0M, vs. FactSet Est of $10.6M
May 12, 8:01 PM · MT Newswires
Wedbush Cuts Price Target on Maze Therapeutics to $48 From $58, Keeps Outperform Rating
Apr 23, 1:12 PM · MT Newswires
Maze Therapeutics Prices $150 Million Securities Offering
Apr 22, 8:49 AM · MT Newswires
Maze Therapeutics, Inc. (MAZE) stock is trading at US$22.52, -3.92% from the previous close of US$23.44.
The market cap for Maze Therapeutics, Inc. (MAZE) stock is approximately US$1.63B.
The 52-week high for Maze Therapeutics, Inc. (MAZE) stock is US$53.65.
The 52-week low for Maze Therapeutics, Inc. (MAZE) stock is US$22.01.
Maze Therapeutics, Inc. (MAZE) does not currently pay a dividend.
Stay on top of MAZE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
